XML 99 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Of Financial Instruments, Derivatives And Hedging Activities
3 Months Ended 12 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Fair Value Disclosures [Abstract]    
Fair Value Of Financial Instruments, Derivatives And Hedging Activities
Financial Instruments
Delphi’s non-derivative financial instruments include debt, which consists of its accounts receivable factoring arrangements, capital leases and other debt issued by Delphi’s non-U.S. subsidiaries, the Tranche A Term Loan, the Tranche B Term Loan (prior to its payoff on March 1, 2013) and the senior notes. The fair value of debt is based on quoted market prices for instruments with public market data or significant other observable inputs for instruments without a quoted public market price (Level 2). As of March 31, 2013 and December 31, 2012, total debt was recorded at $2,478 million and $2,464 million, respectively, and had estimated fair values of $2,610 million and $2,557 million, respectively. For all other financial instruments recorded at March 31, 2013 and December 31, 2012, fair value approximates book value.
Fair Value Measurements
Fair Value Measurements on a Recurring Basis
All derivative instruments are required to be reported on the balance sheet at fair value unless the transactions qualify and are designated as normal purchases or sales. Changes in fair value are reported currently through earnings unless they meet hedge accounting criteria. Delphi’s derivative exposures are with counterparties with long-term investment grade credit ratings. Delphi estimates the fair value of its derivative contracts using an income approach based on valuation techniques to convert future amounts to a single, discounted amount. Estimates of the fair value of foreign currency and commodity derivative instruments are determined using exchange traded prices and rates. Delphi also considers the risk of non-performance in the estimation of fair value, and includes an adjustment for non-performance risk in the measure of fair value of derivative instruments. The non-performance risk adjustment reflects the credit default spread (“CDS”) applied to the net commodity by counterparty and foreign currency exposures by counterparty. When Delphi is in a net derivative asset position, the counterparty CDS rates are applied to the net derivative asset position. When Delphi is in a net derivative liability position, estimates of peer companies’ CDS rates are applied to the net derivative liability position.
In certain instances where market data is not available, Delphi uses management judgment to develop assumptions that are used to determine fair value. This could include situations of market illiquidity for a particular currency or commodity or where observable market data may be limited. In those situations, Delphi generally surveys investment banks and/or brokers and utilizes the surveyed prices and rates in estimating fair value.
As of March 31, 2013 and December 31, 2012, Delphi was in a net derivative asset position of $32 million and $14 million, respectively, and no significant adjustments were recorded for nonperformance risk based on the application of peer companies’ CDS rates and because Delphi’s exposures were to counterparties with investment grade credit ratings.
As of March 31, 2013 and December 31, 2012, Delphi had the following assets measured at fair value on a recurring basis:
 
 
Total      
 
Quoted Prices in
Active Markets
Level 1
 
Significant Other
Observable Inputs
Level 2
 
Significant
Unobservable
Inputs
Level 3
 
 
(in millions)
As of March 31, 2013
 
 
Commodity derivatives
 
$
—

 
$
—

 
$
—

 
$
—

Foreign currency derivatives
 
49

 
—

 
49

 
—

Total
 
$
49

 
$
—

 
$
49

 
$
—

As of December 31, 2012:
 
 
 
 
 
 
 
 
Commodity derivatives
 
$
3

 
$
—

 
$
3

 
$
—

Foreign currency derivatives
 
24

 
—

 
24

 
—

Total
 
$
27

 
$
—

 
$
27

 
$
—


As of March 31, 2013 and December 31, 2012, Delphi had the following liabilities measured at fair value on a recurring basis:
 
 
Total      
 
Quoted Prices in
Active Markets
Level 1
 
Significant Other
Observable Inputs
Level 2
 
Significant
Unobservable
Inputs
Level 3
 
 
(in millions)
As of March 31, 2013
 
 
Commodity derivatives
 
$
16

 
$
—

 
$
16

 
$
—

Foreign currency derivatives
 
1

 
—

 
1

 
—

Total
 
$
17

 
$
—

 
$
17

 
$
—

As of December 31, 2012:
 
 
 
 
 
 
 
 
Commodity derivatives
 
$
8

 
$
—

 
$
8

 
$
—

Foreign currency derivatives
 
5

 
—

 
5

 
—

Total
 
$
13

 
$
—

 
$
13

 
$
—



Fair Value Measurements on a Nonrecurring Basis
In addition to items that are measured at fair value on a recurring basis, Delphi also has items in its balance sheet that are measured at fair value on a nonrecurring basis. As these items are not measured at fair value on a recurring basis, they are not included in the tables above. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets, intangible assets, asset retirement obligations, share-based compensation and liabilities for exit or disposal activities measured at fair value upon initial recognition. No significant impairment charges were recorded during the three months ended March 31, 2013 and 2012. Fair value of long-lived assets is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved and a review of appraisals. As such, Delphi has determined that the fair value measurements of long-lived assets fall in Level 3 of the fair value hierarchy.
FAIR VALUE OF FINANCIAL INSTRUMENTS, DERIVATIVES AND HEDGING ACTIVITIES
Derivatives and Hedging Activities
Delphi is exposed to market risk, such as fluctuations in foreign currency exchange rates, commodity prices and changes in interest rates, which may result in cash flow risks. To manage the volatility relating to these exposures, Delphi aggregates the exposures on a consolidated basis to take advantage of natural offsets. For exposures that are not offset within its operations, Delphi enters into various derivative transactions pursuant to its risk management policies, which prohibit holding or issuing derivative financial instruments for speculative purposes, and designation of derivative instruments is performed on a transaction basis to support hedge accounting. The changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the fair value or cash flows of the underlying exposures being hedged. Delphi assesses the initial and ongoing effectiveness of its hedging relationships in accordance with its documented policy. As of March 31, 2013, Delphi has entered into derivative instruments to hedge cash flows extending out to July 2015.
As of March 31, 2013, the Company had the following outstanding notional amounts related to commodity and foreign currency forward contracts that were entered into to hedge forecasted exposures:
Commodity
 
Quantity
Hedged
 
Unit of
Measure
 
 
(in thousands)
Copper
 
67,882

 
pounds
Primary Aluminum
 
32,377

 
pounds
Secondary Aluminum
 
17,727

 
pounds
Foreign Currency
 
Quantity
Hedged
 
Unit of
Measure
 
 
(in millions)
Hungarian Forint
 
10,009

 
HUF
Mexican Peso
 
6,111

 
MXN
South Korean Won
 
16,125

 
KRW
Thai Baht
 
1,319

 
THB
Chinese Yuan Renminbi
 
378

 
CNY
Romanian Leu
 
242

 
RON
Japanese Yen
 
506

 
JPY
Euro
 
331

 
EUR
New Turkish Lira
 
165

 
TRY
Polish Zloty
 
278

 
PLN
Brazilian Real
 
165

 
BRL
British Pound
 
25

 
GBP

The fair value of derivative financial instruments recorded in the consolidated balance sheets as of March 31, 2013 and December 31, 2012 are as follows:
 
Asset Derivatives
 
Liability Derivatives
 
Net Amounts of Assets and Liabilities Presented in the Balance Sheet
 
Balance Sheet Location
 
March 31,
2013
 
Balance Sheet Location
 
March 31,
2013
 
March 31,
2013
 
(in millions)
 
 
Designated derivatives instruments:
 
 
Commodity derivatives
Other Current Assets
 
$
—

 
Accrued Liabilities
 
$
12

 
 
Foreign currency derivatives*
Other Current Assets
 
44

 
Other Current Assets
 
5

 
39

Foreign currency derivatives*
Accrued Liabilities
 
—

 
Accrued Liabilities
 
1

 
(1
)
Commodity derivatives
Other Long-Term Assets
 
—

 
Other Long-Term Liabilities
 
4

 
 
Foreign currency derivatives*
Other Long-Term Assets
 
12

 
Other Long-Term Assets
 
2

 
10

Total
 
 
$
56

 
 
 
$
24

 
 
Derivatives not designated:
None
 
 
 
 
 
 
 
 
 
 
Asset Derivatives
 
Liability Derivatives
 
Net Amounts of Assets and Liabilities Presented in the Balance Sheet
 
Balance Sheet Location
 
December 31, 2012
 
Balance Sheet Location
 
December 31, 2012
 
December 31, 2012
 
(in millions)
 
 
Designated derivatives instruments:
 
 
Commodity derivatives
Other Current Assets
 
$
2

 
Accrued Liabilities
 
$
7

 
 
Foreign currency derivatives*
Other Current Assets
 
24

 
Other Current Assets
 
5

 
19

Foreign currency derivatives*
Accrued Liabilities
 
—

 
Accrued Liabilities
 
5

 
(5
)
Commodity derivatives
Other Long-Term Assets
 
1

 
Other Long-Term Liabilities
 
1

 
 
Foreign currency derivatives*
Other Long-Term Assets
 
7

 
Other Long-Term Assets
 
2

 
5

Total
 
 
$
34

 
 
 
$
20

 
 
Derivatives not designated:
None
 
 
 
 
 
 
 
 
 
 * Derivative instruments within this category are subject to master netting arrangements and are presented on a net basis in the consolidated balance sheets in accordance with accounting guidance related to the offsetting of amounts related to certain contracts.
The fair value of Delphi’s derivative financial instruments remained in a net asset position at March 31, 2013 and December 31, 2012. The net asset position increased at March 31, 2013 primarily due to favorable movements in the forward rates of certain currencies.
The effect of derivative financial instruments in the consolidated statement of operations and and consolidated statement of comprehensive income for the three months ended March 31, 2013 is as follows:
Three Months Ended March 31, 2013
 
(Loss) Gain
Recognized in
OCI (Effective
Portion)
 
(Loss) Gain
Reclassified
from OCI
into Income
(Effective
Portion)
 
Gain Recognized
in Income
(Ineffective
Portion Excluded
from Effectiveness
Testing)
 
 
(in millions)
Designated derivatives instruments:
 
 
 
 
 
 
Commodity derivatives
 
$
(15
)
 
$
(3
)
 
$
—

Foreign currency derivatives
 
35

 
15

 
—

Total
 
$
20

 
$
12

 
$
—

 
Loss
Recognized in
Income
Derivatives not designated:
 
Commodity derivatives
$
—

Foreign currency derivatives
(1
)
Total
$
(1
)
The effect of derivative financial instruments in the consolidated statement of operations and consolidated statement of comprehensive income for the three months ended March 31, 2012 is as follows:
Three Months Ended March 31, 2012
 
Gain
Recognized in
OCI (Effective
Portion)
 
Loss
Reclassified
from OCI
into Income
(Effective
Portion)
 
Loss Recognized
in Income
(Ineffective
Portion Excluded
from Effectiveness
Testing)
 
 
(in millions)
Designated derivatives instruments:
 
 
 
 
 
 
Commodity derivatives
 
$
27

 
$
(2
)
 
$
—

Foreign currency derivatives
 
50

 
(1
)
 
—

Total
 
$
77

 
$
(3
)
 
$
—

 
Loss
Recognized in
Income
Derivatives not designated:
 
Commodity derivatives
$
—

Foreign currency derivatives
(1
)
Total
$
(1
)

The gain or loss reclassified from OCI into income for the effective portion of designated derivative instruments and the gain or loss recognized in income for the ineffective portion of designated derivative instruments excluded from effectiveness testing were recorded to cost of sales and other income in the consolidated statements of operations for the three months ended March 31, 2013 and 2012. The gain or loss recognized in income for non-designated derivative instruments was recorded in other income, net and cost of goods sold for the three months ended March 31, 2013 and 2012.
Gains and losses on derivatives qualifying as cash flow hedges are recorded in OCI, to the extent that hedges are effective, until the underlying transactions are recognized in earnings. Unrealized amounts in accumulated OCI will fluctuate based on changes in the fair value of hedge derivative contracts at each reporting period. Income included in accumulated OCI as of March 31, 2013 was approximately $30 million (approximately $20 million net of tax). Of this income, approximately $20 million is expected to be included in cost of sales within the next 12 months, $2 million is expected to be included in other income within the next 12 months and $8 million is expected to be included in cost of sales in subsequent periods. Cash flow hedges are discontinued when Delphi determines it is no longer probable that the originally forecasted transactions will occur. The amount included in cost of sales related to hedge ineffectiveness was approximately $0 million and $0 million for the three months ended March 31, 2013 and 2012, respectively.